GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹0.98 Cr | ₹0.98 Cr | - | ₹0.74 Cr | ₹1.70 Cr |
What is the latest Contingent Liabilities ratio of GENNEX LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹0.98 Cr |
| Mar2024 | ₹0.98 Cr |
| Mar2023 | - |
| Mar2022 | ₹0.74 Cr |
| Mar2021 | ₹1.70 Cr |
How is Contingent Liabilities of GENNEX LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.98 Cr | 0.00 | |
| Mar2024 | ₹0.98 Cr | 0 | |
| Mar2023 | - | -100.00 | |
| Mar2022 | ₹0.74 Cr | -56.70 | |
| Mar2021 | ₹1.70 Cr | - | |
Compare Contingent Liabilities of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹272.0 Cr | -5.2% | -8.7% | -16.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,195.0 Cr | 3% | 9.5% | 3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,849.0 Cr | 1.7% | 3.1% | 5.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,586.0 Cr | 4.7% | 11.7% | 41.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,054.0 Cr | 2.1% | 6.7% | 11.6% | Stock Analytics | |
| CIPLA | ₹108,703.0 Cr | 1.3% | 1.3% | -9.4% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -5.2% |
-8.7% |
-16.5% |
| SENSEX | -1.7% |
0.5% |
8.3% |
You may also like the below Video Courses